A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 18,630 shares of DXCM stock, worth $1.41 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,630
Holding current value
$1.41 Million
% of portfolio
0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$64.0 - $116.06 $1.19 Million - $2.16 Million
18,630 New
18,630 $1.25 Million
Q3 2023

Oct 30, 2023

SELL
$86.06 - $137.93 $91,739 - $147,033
-1,066 Reduced 99.91%
1 $0
Q2 2023

Jul 17, 2023

BUY
$112.47 - $130.98 $120,005 - $139,755
1,067 New
1,067 $136,000
Q1 2022

May 03, 2022

SELL
$94.08 - $130.2 $3,198 - $4,426
-34 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$129.87 - $162.82 $4,415 - $5,535
34 New
34 $18,000
Q1 2021

Apr 27, 2021

SELL
$84.79 - $104.74 $131,339 - $162,242
-1,549 Closed
0 $0
Q4 2020

Jan 26, 2021

SELL
$78.0 - $104.5 $3,198 - $4,284
-41 Reduced 2.58%
1,549 $1.84 Million
Q3 2020

Oct 20, 2020

BUY
$95.51 - $112.95 $132,758 - $157,000
1,390 Added 695.0%
1,590 $655,000
Q2 2020

Jul 14, 2020

BUY
$62.68 - $105.34 $12,536 - $21,068
200 New
200 $81,000
Q1 2020

Apr 28, 2020

SELL
$47.79 - $75.63 $8,506 - $13,462
-178 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$36.62 - $57.29 $2,307 - $3,609
63 Added 54.78%
178 $39,000
Q2 2019

Jul 22, 2019

SELL
$27.84 - $38.92 $15,868 - $22,184
-570 Reduced 83.21%
115 $17,000
Q1 2019

Apr 18, 2019

BUY
$28.07 - $38.18 $11,396 - $15,501
406 Added 145.52%
685 $81,000
Q4 2018

Jan 29, 2019

BUY
$26.99 - $37.37 $7,530 - $10,426
279 New
279 $33,000
Q4 2017

Feb 01, 2018

SELL
$11.12 - $15.38 $3,002 - $4,152
-270 Closed
0 $0
Q3 2017

Nov 02, 2017

BUY
$11.36 - $18.98 $3,067 - $5,124
270
270 $13,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.